AdvaMed’s Jeff Ezell
This article was originally published in The Gray Sheet
Executive Summary
Media relations director is promoted to associate VP-diagnostics, effective Dec. 1, coordinating activities of AdvaMed's IVD sector, comprised of more than 50 member companies. Ezell, who joined the trade group in 2000 after a stint at Edelman PR, will work closely with AdvaMed staffers Carolyn Jones and Stephanie Mensh, attempting to help diagnostic firms realize a five-year objective to increase "brand awareness" for the industry as a whole, with an eye toward obtaining more favorable reimbursement...
You may also be interested in...
AdvaMed rebranding
VP-public affairs will be Porter Novelli's current VP-Consumer Group Mary Anne Hansan. She joins the trade association Nov. 30, replacing Lisa Wolfington, who left in June. At the Washington, D.C. office of the PR firm, Hansan led "consumer brand and safety communications" for the propane industry, AdvaMed notes. She has served as a media contact for the American Chemistry Council and advertising director of the American Plastics Council. Soon after her arrival, Hansan will choose a director of media relations - a spot to be vacated by Jeff Ezell Dec. 1. Ezell will focus on "brand awareness" for diagnostic member companies (1"The Gray Sheet" Nov. 8, 2004, In Brief). An exec-VP-federal government relations post - formerly occupied by Steve Ubl, who left to form his own consultancy in July - remains to be filled. AdvaMed's board convenes in Washington, D.C. Dec. 8-9...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.